JP2022554357A5 - - Google Patents
Info
- Publication number
- JP2022554357A5 JP2022554357A5 JP2022526004A JP2022526004A JP2022554357A5 JP 2022554357 A5 JP2022554357 A5 JP 2022554357A5 JP 2022526004 A JP2022526004 A JP 2022526004A JP 2022526004 A JP2022526004 A JP 2022526004A JP 2022554357 A5 JP2022554357 A5 JP 2022554357A5
- Authority
- JP
- Japan
- Prior art keywords
- trna
- pharmaceutical composition
- nucleotide sequence
- expression vector
- gene product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025116258A JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962929428P | 2019-11-01 | 2019-11-01 | |
| US62/929,428 | 2019-11-01 | ||
| PCT/US2020/058415 WO2021087401A1 (en) | 2019-11-01 | 2020-10-30 | Methods and compositions for treating a premature termination codon-mediated disorder |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116258A Division JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022554357A JP2022554357A (ja) | 2022-12-28 |
| JP2022554357A5 true JP2022554357A5 (enExample) | 2024-11-06 |
| JP7712270B2 JP7712270B2 (ja) | 2025-07-23 |
Family
ID=75715359
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526004A Active JP7712270B2 (ja) | 2019-11-01 | 2020-10-30 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| JP2025116258A Pending JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025116258A Pending JP2025148444A (ja) | 2019-11-01 | 2025-07-10 | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12697350B2 (enExample) |
| EP (1) | EP4051291A4 (enExample) |
| JP (2) | JP7712270B2 (enExample) |
| KR (1) | KR20220155981A (enExample) |
| CN (2) | CN119955780A (enExample) |
| AU (1) | AU2020375040A1 (enExample) |
| CA (1) | CA3156791A1 (enExample) |
| WO (1) | WO2021087401A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| MX2020004587A (es) | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| JP7712270B2 (ja) | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| BR112022020780A2 (pt) * | 2020-04-14 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Composições de trem e usos das mesmas |
| EP4334450A4 (en) * | 2021-05-05 | 2025-06-18 | Tevard Biosciences, Inc. | Methods and compositions for treating a premature termination codon-mediated disorder |
| CA3235264A1 (en) * | 2021-10-13 | 2023-04-20 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods of use |
| CA3249261A1 (en) | 2022-04-18 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | COMPOSITIONS AND PROCESSES TO IMPROVE ADENE-ASSOCIATED VIRUS (AAV) THERAPY AND REDUCE AAV TROPISM TO THE LIVER |
| WO2023220342A2 (en) * | 2022-05-13 | 2023-11-16 | Shape Therapeutics Inc. | Engineered tranfer rnas |
| WO2024155745A1 (en) * | 2023-01-18 | 2024-07-25 | The Broad Institute, Inc. | Base editing-mediated readthrough of premature termination codons (bert) |
| EP4652272A1 (en) * | 2023-01-18 | 2025-11-26 | The Broad Institute Inc. | Prime editing-mediated readthrough of premature termination codons (pert) |
| EP4442826A1 (en) | 2023-04-06 | 2024-10-09 | Universität Hamburg | Synthetic dna construct encoding transfer rna |
| EP4702142A1 (en) * | 2023-04-28 | 2026-03-04 | University of Rochester | A method of treating a premature translation termination codon n1n2n3 (ptc)-related disease by nonsense suppression in a subject |
| EP4458967A1 (en) | 2023-05-02 | 2024-11-06 | Universität Hamburg | Pharmaceutical composition comprising multiple suppressor transfer rnas |
| WO2025111506A1 (en) * | 2023-11-22 | 2025-05-30 | Tevard Biosciences, Inc. | Modified transfer rnas and methods of use |
| WO2025119204A1 (en) * | 2023-12-04 | 2025-06-12 | Modit Therapeutics Beijing Limited | Methods and compositions for improved readthrough of pseudouridine-modified codons |
| WO2026030209A1 (en) * | 2024-07-29 | 2026-02-05 | University Of Rochester | Use of decoding trnas to boost protein expression or function |
| WO2026136461A1 (en) * | 2024-12-17 | 2026-06-25 | The Broad Institute, Inc. | Prime editing-mediated readthrough of premature termination codons (pert) |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4687737A (en) | 1982-11-12 | 1987-08-18 | Massachusetts Institute Of Technology | Mammalian suppressor genes |
| US5840702A (en) | 1996-03-22 | 1998-11-24 | Uab Research Foundation | Cystic fibrosis treatment |
| US7351578B2 (en) | 1999-12-10 | 2008-04-01 | Invitrogen Corp. | Use of multiple recombination sites with unique specificity in recombinational cloning |
| JP2002508959A (ja) | 1998-01-14 | 2002-03-26 | ヒューマン ジーン セラピー リサーチ インスティテュート | ヒトのサプレッサーｔＲＮＡオリゴヌクレオチド、及びそれを用いる方法 |
| CA2449950A1 (en) | 2001-06-13 | 2002-12-27 | Masayuki Arakawa | Agents for treating diseases caused by nonsense mutation |
| WO2003033521A1 (en) | 2001-10-16 | 2003-04-24 | Massachusetts Institute Of Technology | Inppressor trna system in mammalian cells for the introduction of unnatural amino acids in polypeptides. |
| US20040219516A1 (en) | 2002-07-18 | 2004-11-04 | Invitrogen Corporation | Viral vectors containing recombination sites |
| KR101423898B1 (ko) | 2005-12-14 | 2014-07-28 | 암브룩스, 인코포레이티드 | 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도 |
| GB0600948D0 (en) | 2006-01-18 | 2006-02-22 | Univ Dundee | Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders |
| FR2902439A1 (fr) | 2006-06-14 | 2007-12-21 | Univ Rene Descartes Paris V Et | Arn de transfert chimerique et son utilisation pour la production d'arn par une cellule |
| WO2009086497A2 (en) | 2007-12-28 | 2009-07-09 | Ardell David H | Genetic encryption |
| US20120077186A1 (en) | 2010-05-07 | 2012-03-29 | Oregon Health & Science University | Use of cysteine-derived suppressor trnas for non-native amino acid incorporation |
| CN109112126B (zh) * | 2010-06-23 | 2024-06-14 | 库尔纳公司 | 通过抑制电压门控钠通道α亚基(SCNA)的天然反义转录物而治疗SCNA相关疾病 |
| KR101991980B1 (ko) * | 2011-09-06 | 2019-06-21 | 큐알엔에이, 인크. | 소형 분자로 전압-개폐된 나트륨 채널 (SCNxA)의 알파 아단위에 관련된 질환의 치료 |
| US10513699B2 (en) | 2014-09-03 | 2019-12-24 | Bioatla, Llc | Discovering and producing conditionally active biologic proteins in the same eukaryotic cell production hosts |
| HRP20170589T2 (hr) | 2014-12-22 | 2023-05-12 | Sandoz Ag | Varijante sekvenci |
| US10900036B2 (en) | 2015-03-17 | 2021-01-26 | The General Hospital Corporation | RNA interactome of polycomb repressive complex 1 (PRC1) |
| US20180171321A1 (en) | 2015-03-27 | 2018-06-21 | The University Of Queensland | Platform for a non-natural amino acid incorporation into proteins |
| WO2017049409A1 (en) | 2015-09-25 | 2017-03-30 | The Centre For Drug Research And Development | Compositions for promoting readthrough of premature termination codons, and methods of using the same |
| CN107177592B (zh) | 2016-03-10 | 2021-03-30 | 北京大学 | 抑制性tRNA通读提前终止密码子疾病中的截短蛋白 |
| PL3458074T3 (pl) | 2016-05-16 | 2024-11-12 | Board Of Regents Of The University Of Texas System | KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA |
| WO2018031531A1 (en) | 2016-08-08 | 2018-02-15 | President And Fellows Of Harvard College | Engineered bacteria for non-invasive imaging and therapeutic applications |
| WO2018041973A1 (en) * | 2016-09-01 | 2018-03-08 | Proqr Therapeutics Ii B.V. | Chemically modified single-stranded rna-editing oligonucleotides |
| CN110612353A (zh) | 2017-03-03 | 2019-12-24 | 加利福尼亚大学董事会 | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 |
| MX2020004587A (es) * | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| AU2019233673B2 (en) | 2018-03-15 | 2025-05-01 | Arcturus Therapeutics, Inc. | Synthetic transfer RNA with extended anticodon loop |
| WO2020069194A1 (en) | 2018-09-26 | 2020-04-02 | Case Western Reserve University | Methods and compositions for treating a premature stop codon-mediated disorder |
| EA202190736A1 (ru) | 2018-09-26 | 2021-09-16 | Кейс Вестерн Ризерв Юниверсити | Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью |
| JP2022528696A (ja) | 2019-04-11 | 2022-06-15 | アークタラス テラピュウティクス、インク | アンチコドンループを延長した合成転移ｒｎａ |
| EP4041317A4 (en) | 2019-10-11 | 2024-05-22 | University of Massachusetts | RAAV-MEDIATED IN VIVO ADMINISTRATION OF ARNT SUPPRESSANTS |
| JP7712270B2 (ja) | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| CA3160097A1 (en) | 2019-11-04 | 2021-05-14 | Flagship Pioneering, Inc. | Trem compositions for con-rare codons and related uses |
| JP2023504661A (ja) | 2019-12-02 | 2023-02-06 | シェイプ・セラピューティクス・インコーポレイテッド | 疾患の処置のための標的化トランスファーｒｎａ |
| EP4334450A4 (en) | 2021-05-05 | 2025-06-18 | Tevard Biosciences, Inc. | Methods and compositions for treating a premature termination codon-mediated disorder |
-
2020
- 2020-10-30 JP JP2022526004A patent/JP7712270B2/ja active Active
- 2020-10-30 EP EP20882711.3A patent/EP4051291A4/en active Pending
- 2020-10-30 US US17/773,112 patent/US12697350B2/en active Active
- 2020-10-30 CN CN202411915548.9A patent/CN119955780A/zh active Pending
- 2020-10-30 KR KR1020227018429A patent/KR20220155981A/ko not_active Ceased
- 2020-10-30 CN CN202080090997.8A patent/CN115209902B/zh active Active
- 2020-10-30 WO PCT/US2020/058415 patent/WO2021087401A1/en not_active Ceased
- 2020-10-30 AU AU2020375040A patent/AU2020375040A1/en not_active Abandoned
- 2020-10-30 CA CA3156791A patent/CA3156791A1/en active Pending
-
2025
- 2025-07-10 JP JP2025116258A patent/JP2025148444A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11603540B2 (en) | Phagemid vector | |
| CN106471125B (zh) | 包括白蛋白结合部分的腺病毒 | |
| JP2022501055A5 (enExample) | ||
| KR20180120204A (ko) | 공기 매개 병원체 및 자극물질에 대한 보호용 조성물 및 방법 | |
| CN114729331A (zh) | 化学修饰的腺相关病毒 | |
| JP5943996B2 (ja) | 腫瘍溶解性強化Ｂ型ヒトアデノウイルスＡｄ１１突然変異体の構築とその応用 | |
| WO2021042944A1 (zh) | 肌肉靶向的微环dna基因治疗 | |
| CN111067868B (zh) | 一种载药囊泡 | |
| CN1347450A (zh) | 用于保存感染性重组腺病毒的组合物 | |
| Li et al. | CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo | |
| JP2006511212A5 (enExample) | ||
| Hernandez et al. | Activated and nonactivated MSCs increase survival in humanized mice after acute liver injury through alcohol binging | |
| Grisendi et al. | Tumor stroma manipulation by MSC | |
| JP2005526520A5 (enExample) | ||
| Marukawa et al. | Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma | |
| JP2025510975A5 (enExample) | ||
| Sato et al. | Extracellular vesicles derived from murine cementoblasts possess the potential to increase receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis | |
| CN120464586A (zh) | 一种用于罕少见基因突变的实体瘤治疗的重组溶瘤病毒 | |
| KR100913860B1 (ko) | 올리고뉴클레오타이드 조성물 및 세포 분화 유도시 이의용도 | |
| US12576112B2 (en) | Inhibition of TNF-alpha by fibroblasts and fibroblast exosomes | |
| JP2022512903A (ja) | Ａｄ－ＲＥＩＣ／Ｄｋｋ－３とチェックポイント阻害剤とを用いた胸部がんの治療のための併用療法 | |
| WO2023133525A1 (en) | Optimized polynucleotides for protein expression | |
| US20240139345A1 (en) | Nucleic acid vectors and methods of use | |
| Li et al. | Protection of mice from lethal endotoxemia by chimeric human BPI-Fcgamma1 gene delivery | |
| KR20240000477A (ko) | 암 치료용 아데노바이러스 |